922 related articles for article (PubMed ID: 1665741)
21. L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.
Moritoki H; Ueda H; Yamamoto T; Hisayama T; Takeuchi S
Br J Pharmacol; 1991 Apr; 102(4):841-6. PubMed ID: 1649658
[TBL] [Abstract][Full Text] [Related]
22. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
24. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
25. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity: roles of endothelium, phosphodiesterase, and K+ channel.
Wu BN; Chen IC; Lin RJ; Chiu CC; An LM; Chen IJ
J Cardiovasc Pharmacol; 2005 Nov; 46(5):600-8. PubMed ID: 16220066
[TBL] [Abstract][Full Text] [Related]
26. The effects of selective phosphodiesterase III and V inhibitors on adrenergic and non-adrenergic, non-cholinergic relaxation responses of guinea-pig pulmonary arteries.
Tasatargil A; Sadan G; Ozdem SS
Auton Autacoid Pharmacol; 2003 Apr; 23(2):117-24. PubMed ID: 14511071
[TBL] [Abstract][Full Text] [Related]
27. Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta.
Topouzis S; Schott C; Stoclet JC
J Cardiovasc Pharmacol; 1991 Nov; 18(5):670-8. PubMed ID: 1723763
[TBL] [Abstract][Full Text] [Related]
28. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G
J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728
[TBL] [Abstract][Full Text] [Related]
29. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
30. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
31. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
[TBL] [Abstract][Full Text] [Related]
32. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
Wu BN; Lin RJ; Lo YC; Shen KP; Wang CC; Lin YT; Chen IJ
Br J Pharmacol; 2004 Aug; 142(7):1105-14. PubMed ID: 15237094
[TBL] [Abstract][Full Text] [Related]
33. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
34. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
[TBL] [Abstract][Full Text] [Related]
35. Relaxation of rat thoracic aorta induced by the Ca(2+)-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation.
Moritoki H; Hisayama T; Takeuchi S; Kondoh W; Imagawa M
Br J Pharmacol; 1994 Mar; 111(3):655-62. PubMed ID: 7517325
[TBL] [Abstract][Full Text] [Related]
36. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Weir CJ; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):162-6. PubMed ID: 1646055
[TBL] [Abstract][Full Text] [Related]
37. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
38. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1beta-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction.
Takizawa S; Ozaki H; Karaki H
Eur J Pharmacol; 1997 Jul; 330(2-3):143-50. PubMed ID: 9253947
[TBL] [Abstract][Full Text] [Related]
40. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
